ArticleThe British journal of dermatology2015

Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report'.

M B Faries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.